Cisplatin
- Product NDC
- 65219-359
- 11-digit product format
- 652190359
- Labeler code
- 65219
- Product ID
- 65219-359_a91e4890-e792-422b-92f3-8eb99c31aeb7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CISPLATIN
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
- Marketing start
- 2023-09-01
- Substance
- CISPLATIN
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cisplatin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CISPLATIN | 1 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | Q20Q21Q62J |
| Rxcui | 309311 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65219-359-50 | Cisplatin | 50 mL in 1 VIAL | INJECTION, SOLUTION | 50 | | 2 |
| 65219-359-50 | Cisplatin | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65219-359 | CISPLATIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | Current NDC, 2 package rows | 20240316_851e111b-d7c9-4781-849b-3d036e13ce3f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Status |
|---|
| 65219-359-50 | 65219035950 | 50 mL in 1 VIAL | 50 ml | Historical |